128 related articles for article (PubMed ID: 19824055)
21. Bone formation is impaired in a model of type 1 diabetes.
Thrailkill KM; Liu L; Wahl EC; Bunn RC; Perrien DS; Cockrell GE; Skinner RA; Hogue WR; Carver AA; Fowlkes JL; Aronson J; Lumpkin CK
Diabetes; 2005 Oct; 54(10):2875-81. PubMed ID: 16186388
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
Schwarz EM; Lu AP; Goater JJ; Benz EB; Kollias G; Rosier RN; Puzas JE; O'Keefe RJ
J Orthop Res; 2000 May; 18(3):472-80. PubMed ID: 10937636
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments.
Li N; Xu Z; Wooley PH; Zhang J; Yang SY
Drug Des Devel Ther; 2014; 8():1-11. PubMed ID: 24376342
[TBL] [Abstract][Full Text] [Related]
24. Insulin promotes bone formation in augmented maxillary sinus in diabetic rabbits.
Hou CJ; Liu JL; Li X; Bi LJ
Int J Oral Maxillofac Surg; 2012 Mar; 41(3):400-7. PubMed ID: 22099315
[TBL] [Abstract][Full Text] [Related]
25. Effect of naringin collagen graft on bone formation.
Wong RW; Rabie AB
Biomaterials; 2006 Mar; 27(9):1824-31. PubMed ID: 16310246
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of luteolin on titanium particle-induced osteolysis in a mouse model.
Shin DK; Kim MH; Lee SH; Kim TH; Kim SY
Acta Biomater; 2012 Sep; 8(9):3524-31. PubMed ID: 22583904
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
[TBL] [Abstract][Full Text] [Related]
28. The effect of streptozotocin-induced experimental diabetes mellitus on calvarial defect healing and bone turnover in the rat.
Shyng YC; Devlin H; Sloan P
Int J Oral Maxillofac Surg; 2001 Feb; 30(1):70-4. PubMed ID: 11289625
[TBL] [Abstract][Full Text] [Related]
29. Decrease in particle-induced osteolysis in ovariectomized mice.
Nich C; Marchadier A; Sedel L; Petite H; Vidal C; Hamadouche M
J Orthop Res; 2010 Feb; 28(2):178-83. PubMed ID: 19725120
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.
Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM
J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293
[TBL] [Abstract][Full Text] [Related]
31. Blockade of vascular endothelial growth factor activity suppresses wear debris-induced inflammatory osteolysis.
Ren W; Zhang R; Markel DC; Wu B; Peng X; Hawkins M; Wooley PH
J Rheumatol; 2007 Jan; 34(1):27-35. PubMed ID: 17216676
[TBL] [Abstract][Full Text] [Related]
32. Cross-linked N-telopeptide of type I collagen (NTx) in urine as a predictor of periprosthetic osteolysis.
von Schewelov T; Carlsson A; Dahlberg L
J Orthop Res; 2006 Jul; 24(7):1342-8. PubMed ID: 16718682
[TBL] [Abstract][Full Text] [Related]
33. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice.
Jung UJ; Lee MK; Park YB; Kang MA; Choi MS
Int J Biochem Cell Biol; 2006; 38(7):1134-45. PubMed ID: 16427799
[TBL] [Abstract][Full Text] [Related]
34. Antisense oligonucleotide targeting TNF-alpha can suppress Co-Cr-Mo particle-induced osteolysis.
Dong L; Wang R; Zhu YA; Wang C; Diao H; Zhang C; Zhao J; Zhang J
J Orthop Res; 2008 Aug; 26(8):1114-20. PubMed ID: 18327794
[TBL] [Abstract][Full Text] [Related]
35. The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria.
Tatro JM; Taki N; Islam AS; Goldberg VM; Rimnac CM; Doerschuk CM; Stewart MC; Greenfield EM
J Orthop Res; 2007 Mar; 25(3):361-9. PubMed ID: 17106883
[TBL] [Abstract][Full Text] [Related]
36. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting wear particles-induced osteolysis with naringin.
Yu X; Zhao X; Wu T; Zhou Z; Gao Y; Wang X; Zhang CQ
Int Orthop; 2013 Jan; 37(1):137-43. PubMed ID: 23111634
[TBL] [Abstract][Full Text] [Related]
38. Polyethylene particle-induced bone resorption in substance P-deficient mice.
Wedemeyer C; Neuerburg C; Pfeiffer A; Heckelei A; von Knoch F; Hilken G; Brankamp J; Henschke F; von Knoch M; Löer F; Saxler G
Calcif Tissue Int; 2007 Apr; 80(4):268-74. PubMed ID: 17401694
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation.
Epstein NJ; Warme BA; Spanogle J; Ma T; Bragg B; Smith RL; Goodman SB
J Orthop Res; 2005 May; 23(3):501-10. PubMed ID: 15885468
[TBL] [Abstract][Full Text] [Related]
40. Particle-induced osteolysis in three-dimensional micro-computed tomography.
Wedemeyer C; Xu J; Neuerburg C; Landgraeber S; Malyar NM; von Knoch F; Gosheger G; von Knoch M; Löer F; Saxler G
Calcif Tissue Int; 2007 Nov; 81(5):394-402. PubMed ID: 17952672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]